Secondary tabs
Contact details
Antonella Delmestri
Main
Publications
Data source publications
- The General Practice Research Database: Now and the Future (2007)
- The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrations (2019)
- Data Resource Profile: Clinical Practice Research Datalink (CPRD) (2015)
- Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource (2012)
- The General Practice Research Database: Role in Pharmacovigilance (2004)
Studies
List of studies that have been conducted using the data source
- DARWIN EU® Characterization of patients with chronic hepatitis B and C
- Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids: Protopic JOint European Longitudinal Lymphoma and skin cancer Evaluation (JOELLE) Study
- DARWIN EU® - Co-prescribing of endothelin receptor antagonists (ERAs) and phosphodiesterate-5 inhibitors (PDE-5is) in pulmonary arterial hypertension (PAH)
- DARWIN EU® Treatment patterns of drugs used in adult and paediatric population with systemic lupus erythematosus
- DARWIN EU® EHDS Use Case: Natural history of coagulopathy in COVID-19 patients and persons vaccinated against SARS-CoV-2 in the context of the OMICRON variant
- DARWIN EU® Drug utilisation study of medicines with prokinetic properties in children and adults diagnosed with gastroparesis
- DARWIN EU® Natural history of dermatomyositis (DM) and polymyositis (PM) in adults and paediatric populations
- DARWIN EU® Rates of occurrence of treatment-related intercurrent events in patients with major depressive disorder
- DARWIN EU® Effectiveness of COVID-19 vaccines on severe COVID-19 and post acute outcomes of SARS-CoV-2 infection
- DARWIN EU® Age specific incidence rates of RSV related disease in Europe
- DARWIN EU® Monitoring prescription of medicines for public health emergencies at risk of shortages
- DARWIN EU® Effectiveness of Human Papillomavirus Vaccines (HPV) to prevent cervical cancer
- DARWIN EU® Comparing direct and indirect methods to estimate prevalence of chronic diseases using real-world data
- DARWIN EU® – Frailty and polypharmacy among adults with selected cancers at the time of diagnosis
- DARWIN EU® - Chondrosarcoma: patient demographics, treatments, and survival in the period 2010-2023
- DARWIN EU® - Characterising interstitial lung disease in Europe
- SAFETY-VAC: Network of Data Sources for Vaccine Safety Evaluation
- The utilisation of antiepileptics in men and women of childbearing age, and pregnant women in Europe (ADEPT)
- DARWIN EU® – Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications
- DARWIN EU® - Drug Utilisation Study on GLP-1 Receptor Agonists
- SAFETY-VAC: Background incidence estimation of flares of pre-existing chronic diseases using pan-European electronic healthcare data sources. (SAFETY VAC)
- ADEPT: feasibility of estimating the risk of adverse pregnancy, neonatal and child outcomes following either in utero ASM exposure through the mother, or peri-conceptional ASM exposure through the father
- DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe
- DARWIN EU® - Suicidality following exposure to doxycycline
- SAFETY-VAC: Phenotype proposal and rates of immunocompromised populations in real-world data sources.
- DARWIN EU® - Incidence of suicidality in patients with specific chronic skin conditions
- DARWIN EU® - Azathioprine - user characteristics
- DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics
- DARWIN EU® - DUS Characterising STOPP criteria medication use in people with recurrent falls
- DARWIN EU® - Incidence of myoclonus in heart failure: a descriptive analysis in patients treated with sacubitril/valsartan and other treatments
- A post-authorisation safety study of ABRYSVO in immunocompromised, or renally or hepatically impaired adults aged 60 years and older in a real world setting in Europe and UK
- DARWIN EU® -Drug utilisation of salbutamol products for inhalation and therapeutic alternative inhalation products
- DARWIN EU® - Suicidality incidence rates in adult male patients and in patients treated with finasteride and dutasteride
- DARWIN EU® - Characterisation of exposure to acitretin and purpura and related conditions
- DARWIN EU® - Prevalence of hypertrophic cardiomyopathy (HCM) and obstructive hypertrophic cardiomyopathy (oHCM) in six European countries
- DARWIN EU® - Prescription trends of ketamine and esketamine
- DARWIN EU® – Incidence rates of venous thromboembolic events in patients with selected cancers
- DARWIN EU® - Association of venous thromboembolism with non-steroidal anti-inflammatory drug use in women 15-49 years using hormonal contraceptives